Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

FDA Tracking Tweets, Blog Posts To Gauge Reach Of Drug Safety Communications

Executive Summary

FDA is in the early stages of developing a plan for how to get the most dissemination bang for its risk communication bucks.

You may also be interested in...



FDA Gets Social, But Not Too Social

FDA is trying multiple channels in social media to communicate drug safety information, but its two-way communication capacity is lower than many would like.

Can Pfizer’s "Virtual Trial" Change The Game, Cut Development Costs?

As drug makers seek ways to reduce the cost of clinical trials, Pfizer thinks the solution could be asking patients to reach into their own pockets – for their cell phones.

Can Pfizer’s "Virtual Trial" Change The Game, Cut Development Costs?

As drug makers seek ways to reduce the cost of clinical trials, Pfizer thinks the solution could be asking patients to reach into their own pockets – for their cell phones.

Related Content

Topics

UsernamePublicRestriction

Register

PS053419

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel